ClinicalTrials.Veeva

Menu

A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

C

Central South University

Status

Enrolling

Conditions

RPOC
Retained Products of Conception

Treatments

Drug: Expectant care
Procedure: Uterine curettage

Study type

Observational

Funder types

Other

Identifiers

NCT07421895
fkky2022001

Details and patient eligibility

About

The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.

Enrollment

600 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Clinical diagnosis of retained products of conception, and ultrasound indicated that the maximum diameter of the lesion ≥0.5cm.

Exclusion Criteria:1) There is active bleeding requiring immediate surgical intervention;2) combined with obvious infection;3) Combined with severe organ dysfunction, including coagulation dysfunction.

Trial design

600 participants in 2 patient groups

Control group
Description:
After the patient is confirmed to be included in the study, he/she will be hospitalized directly and will undergo hysteroscopic removal of pregnancy products.
Treatment:
Procedure: Uterine curettage
Experimental group
Description:
Wait until a certain time, then surgical treatment if necessary
Treatment:
Drug: Expectant care

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Dabao MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems